AWA
ABBV icon

Alta Wealth Advisors’s AbbVie ABBV Stock Holding History

Alta Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.94M Sell
7,697
-271
-3% -$58.3K 0.53% 42
2026
Q1 		$1.73M Sell
7,968
-44
-0.5% -$9.76K 0.56% 43
2025
Q4 		$1.83M Buy
8,012
+205
+3% +$46.7K 0.61% 37
2025
Q3 		$1.81M Sell
7,807
-250
-3% -$50.9K 0.65% 35
2025
Q2 		$1.5M Buy
8,057
+141
+2% +$26.2K 0.71% 32
2025
Q1 		$1.66M Buy
7,916
+15
+0.2% +$2.92K 0.76% 30
2024
Q4 		$1.4M Sell
7,901
-138
-2% -$25.4K 0.61% 37
2024
Q3 		$1.59M Sell
8,039
-10
-0.1% -$1.87K 0.73% 32
2024
Q2 		$1.38M Hold
8,049
– – 0.69% 36
2024
Q1 		$1.47M Hold
8,049
– – 0.74% 33
2023
Q4 		$1.25M Sell
8,049
-125
-2% -$18.2K 0.7% 38
2023
Q3 		$1.22M Sell
8,174
-248
-3% -$36.4K 0.75% 35
2023
Q2 		$1.13M Sell
8,422
-2,466
-23% -$362K 0.67% 45
2023
Q1 		$1.74M Sell
10,888
-50
-0.5% -$7.64K 1.1% 24
2022
Q4 		$1.77M Sell
10,938
-82
-0.7% -$12.6K 1.19% 23
2022
Q3 		$1.48M Buy
11,020
+81
+0.7% +$11.6K 1.06% 24
2022
Q2 		$1.67M Sell
10,939
-718
-6% -$110K 1.16% 22
2022
Q1 		$1.89M Buy
11,657
+540
+5% +$78.4K 1.12% 23
2021
Q4 		$1.5M Buy
11,117
+122
+1% +$14.4K 0.93% 27
2021
Q3 		$1.19M Sell
10,995
-191
-2% -$21.8K 0.86% 29
2021
Q2 		$1.26M Sell
11,186
-150
-1% -$16.9K 0.92% 29
2021
Q1 		$1.23M Hold
11,336
– – 1.03% 24
2020
Q4 		$1.22M Buy
+11,336
New +$1.09M 1.02% 22

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Alta Wealth Advisors's ABBV Position: Q2 2026 in Review

Alta Wealth Advisors reduced its AbbVie (ABBV) stake by 3.4% in Q2 2026, selling an estimated $58.3K and leaving 7,697 shares worth $1.94M. The position accounts for 0.53% of the portfolio, ranked #42.

Alta Wealth Advisors first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Alta Wealth Advisors held 7,697 shares of AbbVie worth $1.94M as of Q2 2026.
  • Alta Wealth Advisors sold 271 AbbVie shares in Q2 2026, an estimated $58.3K.
  • AbbVie made up 0.53% of Alta Wealth Advisors's portfolio in Q2 2026, its #42 holding.
  • Alta Wealth Advisors first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Alta Wealth Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.